Regeneration Nation LLC
How we got $613K
Based on its 5 employees and its payroll, both reported for PPP in 2020 and brought up to date.
What we know
What they do
Regeneration Nation is a Tulsa, Oklahoma clinic offering regenerative medicine and allergy treatment, aiming to help patients restore function and reduce pain through evaluations and personalized regenerative treatment plans. It serves patients ages 17 to 100+.
From the company's website. Industry: Medical Laboratories.
Estimated value over time
▲ 25% since 2020Today's estimate scaled by the headcount reported each year and that year's prices. A trend, not a record of past sale values.
Compared with similar businesses nearby
| Business | Est. revenue | Distance |
|---|---|---|
| REGENERATION NATION LLC this business | $1.1M | — |
| Kelli Herlihy Dyer Tulsa | $1.7M | 0.0 mi |
| Dr. William J. Lewis Tulsa | $1.7M | 0.0 mi |
| St Francis Laboratories Tulsa | $1.7M | 0.0 mi |
| SmilesOfTulsa Tulsa | $1.7M | 0.0 mi |
| Regenexx of Texas and Oklahoma Tulsa | $1.7M | 0.0 mi |
| Mark Anthony Galles, MD Tulsa | $1.7M | 0.0 mi |
The full calculation
| Employees reported to the SBA | 5 |
| Revenue from headcount (employees × revenue per employee for companies this size) | $1.3M |
| Revenue from PPP payroll (payroll ÷ payroll's share of revenue for companies this size) | $769K |
| Estimate: the two combined (geometric mean) | $1.1M |
| EBITDA margin (industry, adjusted for size) | 22% |
| EBITDA = revenue × margin | $245K |
Figures are shown toward the upper part of their range rather than at its middle.
Brought up to date assuming revenue has grown 8% a year since 2020, when the PPP figures were reported; included above.
| Estimated value = EBITDA × typical sale multiple | $613K |
| Multiple for this size and industry | 2.5× |
| Value range | $323K – $839K |
| Revenue range | $749K – $1.3M |
| EBITDA range | $161K – $280K |
| Industry (NAICS) | Medical Laboratories (621511) |
EBITDA margin: from IRS tax returns of S corporations in this industry (2019–2022), adjusted for company size: smaller companies typically run higher margins. EBITDA here is after owners' salaries.
Benchmarks: US Economic Census 2022, OK. PPP loans were sized on 2019–2020 payroll, so figures reflect that period. These are statistical estimates, not reported financials. Full methodology
People & advisors
Advisors
- BankingArvest BankPPP / SBA lender
From the company's own website and public filings (DOL Form 5500, IRS Form 990, SBA). Roles are as stated there and may be out of date.
Banking relationships
| Arvest Bank PPP 2020, PPP 2021 | All 5,114 borrowers → |
From PPP and SBA loan records, which name the bank but not the individual banker.
PPP loans
| Approved | Draw | Amount | Jobs |
|---|---|---|---|
| 4/13/2020 | first | $33K | 5 |
| 1/23/2021 | second | $83K | 5 |
Public records
Matched to this business by name and address from public government data; a match can occasionally be wrong.
About Regeneration Nation LLC
Regeneration Nation LLC is a medical laboratories company in Tulsa, Oklahoma, in business since 2021. Its estimated annual revenue is about $1.1M, with roughly $245K of EBITDA. It has about 5 employees. Its estimated business value is $613K (likely range $323K–$839K).
Common questions
- Who owns Regeneration Nation LLC?
- The owner of Regeneration Nation LLC isn't in public records we've found yet. If you own or run the business, you can add or correct its details on SeeBITDA.
- How much revenue does Regeneration Nation LLC make?
- SeeBITDA estimates Regeneration Nation LLC's annual revenue at about $1.1M (likely between $749K and $1.3M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.
- What is Regeneration Nation LLC worth?
- About $613K, roughly 2.5× its estimated EBITDA of $245K, typical for a medical laboratories company its size. Likely range: $323K–$839K.
- How many employees does Regeneration Nation LLC have?
- About 5, as reported on its PPP loan.
- When was Regeneration Nation LLC founded?
- Regeneration Nation LLC has been in business since 2021.